Cetuximab induced endoplasmic reticulum (ER) stress and CRT and ERp57 expression on the cell surface, favouring phagocytosis by DCs of dying cancer cells, which triggered the stimulation of a protective T-cell (CD8+) memory immune response observed alone and in combination with FOLFIRI (33). The gene discussed is CD8A; the disease is cancer.